DETROIT — Starting in March, CDK Global Inc. will give its dealership customers the option to share data contained within their dealership management systems and other CDK software tools with ...
Genentech is paying $850 million upfront for Regor Pharmaceuticals’ portfolio of CDK inhibitors, taking ownership of a breast cancer candidate that has shown signs of single-agent efficacy in patients ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results